Human Papillomavirus (HPV)

ADVISORY COMMITTEE ON IMMUNIZATION PRACTICES (ACIP) MEETING

From the US Centers for Disease Control and Prevention (US CDC) website:
Undefined

Nine-valent HPV Vaccine May Prevent Nearly 90 Percent of Cervical Cancers

Because nine human papillomavirus (HPV) subtypes were found to cause the majority of cervical precancers, a nine-valent HPV vaccine currently being investigated may be able to prevent more cervical cancers than current vaccines, according to research published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research.
 
Undefined

Angola to Introduce HPV Vaccine By 2015

Angola has announced the introduction of human papilloma virus vaccination (HPV) in 2015, as part of its national immunisation programme.
 
The fact was announced Thursday in Luanda by the Health minister, José Van-Dúnem.
 
The Health minister was speaking at the opening of 10th International Conference on Treatment of Cancer in Africa, called "AORTIC PALOP", going between 02 and 03 October, under the Oncology Center.
 
The official stressed that the HPV vaccine can combat cervix and oropharynx cancers.
 
Undefined

Call to offer HPV vaccine to boys

It comes amid pressure to extend vaccination to all adolescent boys in the UK, in line with other countries.
 
The committee is expected to focus initially on whether to offer the vaccine to men who have sex with men, who may be at higher risk.
 
But a coalition of health experts and campaigners say vaccinating all boys aged 12 to 13 would save lives.
 
Undefined

CIRC : la période d'essais des vaccins contre le VPH peut être considérablement réduite

Un rapport rédigé par un groupe de travail des experts, conjointement réuni par le Centre international de recherche sur le Cancer (CIRC), agence spécialisée sur le cancer de l'Organisation mondiale de la santé (OMS), et l'Institut national du Cancer des Etats-Unis, agence sanitaire et scientifique américaine, montre comment l'évaluation et l'autorisation des vaccins prophylactiques contre le virus du papillome humain (VPH) pourraient être considérablement accélérées, a annoncé lundi le CIRC sur son site Internet.
 
Undefined

10 questions sur les vaccins et la vaccination

Les vaccins, c’est l’enfer ! Entre le carnet de vaccination perdu ou le médecin contacté en urgence qui ignore tout de notre situation, on ne sait plus vraiment où l’on en est dans notre calendrier de vaccins… Et si on mettait le nez dedans une bonne fois pour toute au lieu de laisser les choses s’enliser ?
 
Mon dernier vaccin date du collège, je dois faire lequel ?
Undefined

More US girls now getting cervical cancer vaccine

More teen girls are getting a controversial cervical cancer vaccine but the increase isn't much of a bump, the government reported Thursday.
 
Last year's rise follows a couple of years when the girls' HPV vaccination rate was flat and health officials worried that it wouldn't budge. For girls ages 13 to 17, the rate is now up to about 38 percent of girls, from 33 percent.
 
"It was better than nothing. But we really need to do better moving forward," said Dr. Anne Schuchat of the Centers for Disease Control and Prevention.
Undefined

HPV Vaccination Coverage Remains Unacceptably Low in the US

Human Papillomavirus (HPV), the leading cause of cervical cancer, is the most common sexually transmitted disease in the US. The virus comes in over 150 forms, and approximately 4 of these can be caught through direct skin-to-skin contact during all types of sex.
 
Some forms of the virus, such as HPV-6 and HPV-11, only cause minor conditions, such as genital warts. The highest risk forms of HPV however, HPV-16 and HPV-18, account for over 70% of cases of cervical cancer and over 5% of all cancer cases world wide.
 
Undefined

HPV Vaccine Cleared Of Link To Blood Clotting

Study shows no link between HPV vaccine and Blood Clotting
 
Undefined

Pages